[{"question": "A 23-year-old man presents to a psychiatrist for evaluation of situational anxiety. He reports that he recently started a new job that involves regular public speaking and is very stressed before every public speaking event. He describes developing a rapid heart rate and diaphoresis that interferes with his ability to speak well. He has no past medical history and takes no medications. He does not smoke or drink alcohol. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 110/65 mmHg, pulse is 85/min, and respirations are 17/min. On exam, he is well-appearing and appropriately conversational. He is alert and fully oriented. The patient is prescribed propranolol to take before major public speaking events. Which of the following physiologic changes will occur when the patient takes this medication?", "correct_answer": "Decreased cardiac output and increased peripheral resistance", "correct_idx": 1, "options": ["A)Decreased cardiac output and decreased peripheral resistance", "B)Decreased cardiac output and increased peripheral resistance", "C)Increased cardiac output and decreased peripheral resistance", "D)Increased cardiac output and increased peripheral resistance"], "prompt": "A 23-year-old man presents to a psychiatrist for evaluation of situational anxiety. He reports that he recently started a new job that involves regular public speaking and is very stressed before every public speaking event. He describes developing a rapid heart rate and diaphoresis that interferes with his ability to speak well. He has no past medical history and takes no medications. He does not smoke or drink alcohol. His temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 110/65 mmHg, pulse is 85/min, and respirations are 17/min. On exam, he is well-appearing and appropriately conversational. He is alert and fully oriented. The patient is prescribed propranolol to take before major public speaking events. Which of the following physiologic changes will occur when the patient takes this medication?A)Decreased cardiac output and decreased peripheral resistance\nB)Decreased cardiac output and increased peripheral resistance\nC)Increased cardiac output and decreased peripheral resistance\nD)Increased cardiac output and increased peripheral resistance", "subject_name": null, "output0": "Propranolol is a beta-blocker medication that is used to treat anxiety and other conditions. One of its primary effects is to decrease cardiac output and peripheral resistance. This can help to reduce the physical symptoms of anxiety, such as a rapid heart rate and diaphoresis, that the patient is experiencing.\n\n", "output1": "The medication propranolol is a beta-blocker, which works by blocking the effects of the hormone epinephrine (adrenaline) on the heart. When the patient takes propranolol before a public speaking event, it will decrease the heart rate and increase the peripheral resistance, which will help to reduce the symptoms of anxiety such as rapid heart rate and diaphoresis.\n\n", "output2": "Propranolol is a beta-blocker that works by blocking the effects of the hormone epinephrine (adrenaline) on the heart. When the patient takes propranolol before a public speaking event, it will increase his cardiac output and decrease his peripheral resistance. This will help to counteract the physiologic changes that occur in response to stress, such as a rapid heart rate and diaphoresis, and allow the patient to speak more effectively.\n\n", "output3": "Propranolol is a beta-blocker medication that works by blocking the effects of adrenaline (epinephrine) on the heart. When taken before a public speaking event, propranolol will increase cardiac output and peripheral resistance, which can help to reduce the physical symptoms of anxiety such as rapid heart rate and diaphoresis.\n\n"}, {"question": "For soldering an orthodontic wire, the solder and flux used are:", "correct_answer": "Silver is used as solder and fluoride as flux", "correct_idx": 2, "options": ["A)Gold is used as solder and fluoride as flux", "B)Gold is used as solder and borax as flux", "C)Silver is used as solder and fluoride as flux", "D)Silver is used as solder and borax as flux"], "prompt": "For soldering an orthodontic wire, the solder and flux used are:A)Gold is used as solder and fluoride as flux\nB)Gold is used as solder and borax as flux\nC)Silver is used as solder and fluoride as flux\nD)Silver is used as solder and borax as flux", "subject_name": "Dental", "output0": "Gold is used as solder because it is a highly malleable and ductile metal that can be easily shaped and manipulated. Fluoride is used as flux because it helps to remove any impurities from the metal and also helps to prevent oxidation.\n\n", "output1": "Gold is used as solder because it has a high melting point and is biocompatible. Borax is used as flux because it helps to remove any impurities from the solder and improve its flow. This is particularly useful when soldering an orthodontic wire, as it helps to ensure a strong and durable bond.\n\n", "output2": "The correct answer is C)Silver is used as solder and fluoride as flux. This is because silver is a more malleable and ductile metal than gold, which makes it easier to shape and mold the wire. Additionally, fluoride is a common ingredient in orthodontic fluxes, as it helps to prevent corrosion and promote the flow of the solder.\n\n", "output3": "Silver is commonly used as solder in orthodontics because of its high ductility and malleability, which allows for easy shaping and bending of the wire. Borax is used as flux to help the solder flow smoothly and adhere well to the metal surfaces.\n\n"}, {"question": "Which of these observations is explained by the so-called \"inert torque effect\"?", "correct_answer": "Thallium shows oxidation states +1 and +3.", "correct_idx": 2, "options": ["A)Aluminum only has a +3 oxidation state.", "B)Noble gases form very few compounds.", "C)Thallium shows oxidation states +1 and +3.", "D)Iron presents oxidation states +2 and +3."], "prompt": "Which of these observations is explained by the so-called \"inert torque effect\"?A)Aluminum only has a +3 oxidation state.\nB)Noble gases form very few compounds.\nC)Thallium shows oxidation states +1 and +3.\nD)Iron presents oxidation states +2 and +3.", "subject_name": "chemistry", "output0": "The inert torque effect is a phenomenon that occurs when an atom in a molecule is surrounded by other atoms that have a higher oxidation state. In this case, the aluminum atom in the molecule has a higher oxidation state than the other atoms, which causes the molecule to have a higher overall oxidation state.\n\n", "output1": "The \"inert torque effect\" refers to the tendency of noble gases to resist forming compounds. This is because noble gases have a full outer energy level, which makes them very stable and reluctant to form bonds with other atoms. As a result, noble gases form very few compounds compared to other elements.\n\n", "output2": "The inert torque effect refers to the tendency of some elements to maintain their oxidation state over time. Thallium is one such element, as it can exist in both the +1 and +3 oxidation states, but it is resistant to changing its oxidation state. This effect is often observed in elements that are not very reactive, such as thallium.\n\n", "output3": "The so-called \"inert torque effect\" refers to the tendency of some elements, such as iron, to maintain a stable oxidation state over time. This effect is due to the energy required to change the oxidation state of the element, and it is observed in elements that have multiple stable oxidation states, such as iron (+2 and +3).\n\n"}, {"question": "In the clinical part of the child due to insulin-like growth factors (insulin-like growth factor; IGF-1) deficiency, thus causing growth retardation phenomenon, which of the following drugs can be used to promote their growth and development?", "correct_answer": "Mecasermin", "correct_idx": 2, "options": ["A)Recombinant human growth hormone (recombinant human growth hormone)", "B)Octreotide", "C)Mecasermin", "D)Pegvisomant"], "prompt": "In the clinical part of the child due to insulin-like growth factors (insulin-like growth factor; IGF-1) deficiency, thus causing growth retardation phenomenon, which of the following drugs can be used to promote their growth and development?A)Recombinant human growth hormone (recombinant human growth hormone)\nB)Octreotide\nC)Mecasermin\nD)Pegvisomant", "subject_name": null, "output0": "Recombinant human growth hormone (rhGH) is a synthetic version of the natural hormone growth hormone, which is produced by the pituitary gland. It is used to treat growth hormone deficiency, which is a common cause of growth retardation in children. By replacing the missing hormone, rhGH can help promote growth and development in children with this condition.\n\n", "output1": "Octreotide is a somatropin analogue, which is used to treat growth hormone deficiency in children. It is a synthetic form of the natural hormone somatropin, which stimulates growth and development.\n\n", "output2": "Mecasermin, also known as recombinant human insulin-like growth factor-1 (IGF-1), is a synthetic version of the naturally occurring hormone IGF-1. It is used to treat growth hormone deficiency and has been shown to promote growth and development in children with this condition.\n\n", "output3": "Pegvisomant is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the production of growth hormone and insulin-like growth factor-1 (IGF-1). It is used to treat growth hormone deficiency in children and adolescents, and has been shown to promote growth and development.\n\n"}, {"question": "Which of the following is used in the management of haemophillic patient?", "correct_answer": "Tranxemic acid", "correct_idx": 0, "options": ["A)Tranxemic acid", "B)Acetic acid", "C)Ascorbic acid", "D)Palmitonic acid"], "prompt": "Which of the following is used in the management of haemophillic patient?A)Tranxemic acid\nB)Acetic acid\nC)Ascorbic acid\nD)Palmitonic acid", "subject_name": "Surgery", "output0": "Tranxemic acid is used in the management of haemophilic patients to prevent and treat bleeding episodes. It works by increasing the clotting factor in the blood, which helps to stop bleeding more quickly.\n\n", "output1": "Acetic acid is used to treat haemophilia patients because it has been shown to be effective in reducing bleeding and promoting clotting.\n\n", "output2": "Ascorbic acid, or vitamin C, is used to treat bleeding disorders such as haemophilia. It helps to promote collagen synthesis and improve blood clotting.\n\n", "output3": "Palmitonic acid is used in the management of haemophilic patients. It is a synthetic derivative of vitamin K, which is used to treat bleeding disorders such as haemophilia.\n\n"}, {"question": "A previously healthy 41-year-old man comes to the physician for evaluation of a 1-month history of painless, intermittent bleeding on defecation, which he discovered while wiping. His younger sister was recently diagnosed with endometrial cancer, and his mother was diagnosed with gastric cancer at 58 years of age. Physical examination shows no abnormalities. Test of the stool for occult blood is positive. Colonoscopy shows a tumor in the ascending colon. Histopathologic examination of the tumor shows a mucinous, poorly-differentiated adenocarcinoma. A mutation of which of the following genes is most likely responsible for this patient's condition?", "correct_answer": "MLH1", "correct_idx": 0, "options": ["A)MLH1", "B)TP53", "C)DCC", "D)KRAS"], "prompt": "A previously healthy 41-year-old man comes to the physician for evaluation of a 1-month history of painless, intermittent bleeding on defecation, which he discovered while wiping. His younger sister was recently diagnosed with endometrial cancer, and his mother was diagnosed with gastric cancer at 58 years of age. Physical examination shows no abnormalities. Test of the stool for occult blood is positive. Colonoscopy shows a tumor in the ascending colon. Histopathologic examination of the tumor shows a mucinous, poorly-differentiated adenocarcinoma. A mutation of which of the following genes is most likely responsible for this patient's condition?A)MLH1\nB)TP53\nC)DCC\nD)KRAS", "subject_name": null, "output0": "The patient's family history of gastric and endometrial cancer, along with the presence of a mucinous, poorly-differentiated adenocarcinoma in the ascending colon, are indicative of a familial adenomatous polyposis (FAP) syndrome. This is a hereditary condition caused by a mutation in the MLH1 gene, which is responsible for the development of hundreds or thousands of adenomas in the colon and rectum. The patient's positive family history and the presence of a tumor with mucinous features are consistent with this diagnosis.\n\n", "output1": "The patient's family history of cancer, specifically of endometrial and gastric cancer, is a strong risk factor for Lynch syndrome, a condition characterized by inherited mutations in DNA repair genes. TP53 is a tumor suppressor gene that is commonly mutated in Lynch syndrome. The patient's positive family history and the presence of a mucinous, poorly-differentiated adenocarcinoma in the ascending colon are consistent with Lynch syndrome.\n\n", "output2": "The patient's family history of cancer, specifically endometrial and gastric cancer, suggests that the patient may have a hereditary cancer syndrome. The presence of a mucinous, poorly-differentiated adenocarcinoma in the ascending colon, along with the patient's age, also supports this diagnosis. The DCC gene is known to be involved in hereditary colorectal cancer syndromes, such as Turcot syndrome, which is characterized by the presence of multiple colorectal adenomas and a high risk of developing colorectal cancer at a young age. Therefore, a mutation in the DCC gene is most likely responsible for the patient's condition.\n\n", "output3": "The KRAS gene is a tumor suppressor gene that is commonly mutated in colorectal cancer. The patient's family history of gastric and endometrial cancer, as well as the presence of a mucinous, poorly-differentiated adenocarcinoma in the ascending colon, suggest that a KRAS mutation is likely responsible for his condition.\n\n"}, {"question": "A child is able to say short sentences of 6 words \u2013", "correct_answer": "4 years", "correct_idx": 2, "options": ["A)2 years", "B)3 years", "C)4 years", "D)5 years"], "prompt": "A child is able to say short sentences of 6 words \u2013A)2 years\nB)3 years\nC)4 years\nD)5 years", "subject_name": "Pediatrics", "output0": "Children typically begin to speak in short sentences around the age of 2. At this age, they have a limited vocabulary and their sentences are often short and simple.\n\n", "output1": "Children typically begin to use short sentences of 6 words around the age of 3, as they start to develop their language skills further.\n\n", "output2": "Children typically begin to use short sentences of 6 words around the age of 4 years old. By this age, they have developed enough language skills to construct simple sentences and express their thoughts and ideas more clearly.\n\n", "output3": "Children typically develop the ability to say short sentences of 6 words around the age of 5 years old. This is because language development is a gradual process, and children need time to learn and practice new words and sentence structures.\n\n"}, {"question": "Good clinical practice is observed in all phases of clinical trials, EXCEPT?", "correct_answer": "Preclinical", "correct_idx": 0, "options": ["A)Preclinical", "B)Phase I", "C)Phase II", "D)Phase V"], "prompt": "Good clinical practice is observed in all phases of clinical trials, EXCEPT?A)Preclinical\nB)Phase I\nC)Phase II\nD)Phase V", "subject_name": "Dental", "output0": "Good clinical practice is not strictly observed in preclinical studies, as these studies are not subject to the same regulatory requirements as clinical trials. However, it is important to note that preclinical studies should still be conducted with rigor and care to ensure the validity and reliability of the results.\n\n", "output1": "Good clinical practice is not strictly observed in Phase I clinical trials, as the primary goal of this phase is to assess the safety and tolerability of a new drug or intervention. Other aspects of good clinical practice, such as informed consent and data integrity, are still important, but there may be some flexibility in the application of these principles during Phase I trials.\n\n", "output2": "Good clinical practice is not strictly observed in Phase II clinical trials, as the focus is on assessing the efficacy and safety of the intervention, rather than on rigorous methodology.\n\n", "output3": "Phase V is not a phase of clinical trials. There are only four phases of clinical trials: Phase I, Phase II, Phase III, and Phase IV.\n\n"}, {"question": "A 65-year-old male with a history of diabetes, after his right toe injury wound festering wound bacterial culture is ORSA (oxacillin- resistant Staphylococcus aureus). Following an antibiotic that is not suitable?", "correct_answer": "Meropenem", "correct_idx": 1, "options": ["A)Vancomycin", "B)Meropenem", "C)Linezolid", "D)Daptomycin"], "prompt": "A 65-year-old male with a history of diabetes, after his right toe injury wound festering wound bacterial culture is ORSA (oxacillin- resistant Staphylococcus aureus). Following an antibiotic that is not suitable?A)Vancomycin\nB)Meropenem\nC)Linezolid\nD)Daptomycin", "subject_name": null, "output0": "Vancomycin is not suitable for treating ORSA (oxacillin-resistant Staphylococcus aureus) infections. This is because vancomycin is not effective against methicillin-resistant Staphylococcus aureus (MRSA), which is a common cause of ORSA infections.\n\n", "output1": "Meropenem is not a suitable antibiotic for treating ORSA (oxacillin-resistant Staphylococcus aureus) infections. It is a broad-spectrum antibiotic that is effective against many types of bacteria, but it is not effective against ORSA.\n\n", "output2": "Linezolid is not suitable for treating ORSA infections, as it is a macrolide antibiotic and can exacerbate the risk of developing a serious side effect called serotonin syndrome. In contrast, vancomycin, meropenem, and daptomycin are all appropriate options for treating ORSA infections.\n\n", "output3": "Daptomycin is an antibiotic that is effective against ORSA (oxacillin-resistant Staphylococcus aureus), which is the bacterial infection that the patient has. Vancomycin, Meropenem, and Linezolid are not suitable antibiotics for this infection.\n\n"}, {"question": "A primigravida with 36 weeks of pregnancy is in labor with 3 cm dilatation and minimal uterine contraction. On rupture of membranes, fresh bleeding is noted with late fetal deceleration up to 50 beats/min. The patient was taken for LSCS but fetus could no be saved. No abruptio or placenta pre was seen. The likely diagnosis is ?", "correct_answer": "Vasa pre", "correct_idx": 3, "options": ["A)Placenta pre", "B)Revealed abruptio", "C)Circumvallate placenta", "D)Vasa pre"], "prompt": "A primigravida with 36 weeks of pregnancy is in labor with 3 cm dilatation and minimal uterine contraction. On rupture of membranes, fresh bleeding is noted with late fetal deceleration up to 50 beats/min. The patient was taken for LSCS but fetus could no be saved. No abruptio or placenta pre was seen. The likely diagnosis is ?A)Placenta pre\nB)Revealed abruptio\nC)Circumvallate placenta\nD)Vasa pre", "subject_name": "Gynaecology & Obstetrics", "output0": "The likely diagnosis is placenta previa, which is characterized by a placenta that is partially or completely covering the cervix. This can cause bleeding and deceleration of fetal heart rate, as seen in the case. The patient's history of fresh bleeding with late fetal deceleration supports this diagnosis.\n\n", "output1": "The likely diagnosis is revealed abruptio, which is a rare condition where the placenta separates from the uterus but remains attached to the fetus. This can cause bleeding and fetal distress, as seen in the patient's case. The patient's symptoms of fresh bleeding and late fetal deceleration are consistent with this diagnosis.\n\n", "output2": "The patient's symptoms of fresh bleeding and late fetal deceleration are consistent with a circumvallate placenta, which is a condition where the placenta covers the cervix and is not easily visible during delivery. The patient's history of a 36-week pregnancy and 3 cm dilatation also support this diagnosis.\n\n", "output3": "The patient's symptoms of fresh bleeding with late fetal deceleration are consistent with a vasa previa, which is a condition where the fetal blood vessels pass through the placenta and are at risk of rupture. The patient's history of a previous cesarean section and the fact that the fetus could not be saved also support this diagnosis.\n\n"}]